Ronald Chen James Yu See the patient centric video to help #prostatecancer patients understand this important trial: primrmed.com/cancer-clinica…

Recently presented at #ASCO24: A study led by Ronald Chen found that apalutamide/ADT does not appear to negatively impact QOL in recurrent prostate cancer. Learn more via Urology Times: urologytimes.com/view/apalutami…

Nominations for the 2024 ROI Publication Excellence Awards are due 1 month from today! Don't miss your chance to be honored at the ASTRO Annual Meeting and win $1,500. More on eligibility and how to apply at: bit.ly/ROI_Publicatio… #radonc #ASTRO24 ARRO ACROresident

Another day, another fight w/ insurance Aetna denied the chemo for my young pt despite him responding Had to tell him “I don’t know how you sleep at night I hope if a family member of yours ever has cancer they don’t go through someone like you to receive care” I HATE this

Only 1 week remains to apply for the 2024 ROI Publication Excellence Awards and the ARRO DEI Publication Award! Nominate an early career #radonc researcher to win $1,500 and be recognized at #ASTRO24. Details at bit.ly/ROI_Publicatio…. Self nominations accepted.

June 28, 2024. 3:12pm CST. I have won the game. Going home now…

So excited for a new academic year to start! What a privilege to be able to train residents — the future of radiation oncology and medical physics!

So excited for a new academic year to start! What a privilege to be able to train residents — the future of radiation oncology!

Last chance to apply for the 2024 ROI & ARRO publication awards. Get your #radonc nomination in by 5 pm ET today! Fast & easy - complete the short form, write a 1 page nomination statement & attach a copy of your published manuscript. More at bit.ly/ROI_Publicatio…

The University of Kansas Cancer Center was awarded as a top accruing NCORP site to NRG Oncology Trials.

#PRIMR translates medical jargon into patient-friendly language. INNOVATE: apalutamide + standard treatment = improved outcomes? Patients must have lymph node-positive prostate cancer + elevated PSA after surgery to enroll. Watch: primrmed.com/cancer-clinica… Ronald Chen NRG Oncology

Great podcast by Ronald Chen Tracy Balboni MD, MPH, FAAHPM & Dr Alcorn

Using meropenem when amoxicillin will suffice

Head for the Cure 5K to raise funds to defeat brain tumor! University Of Kansas Radiation Oncology KU Cancer Center David Akhavan Dr. Akhavan and Dr. Greg Gan representing! Along with Roy Jensen

Dr. Nina Niu Sanford Krishan Jethwa Neil Newman Hyun Kim Curious the way PROSPECT incorporated to NCCN by only specifying non-T4: -Trial criteria did not include N2 -Required MRF margin of at least 3 mm -More formal guidelines on measuring “20%” would be helpful -No mention in NCCN of adjuvant chemo most received

24 physician strong! Amazing faculty at University Of Kansas Radiation Oncology KU Cancer Center KU Medical Center Successful annual faculty retreat discussing current dept state and future direction.

Excited to have Ryan Morse return home to University Of Kansas Radiation Oncology! KU Cancer Center

Great work by authors from University Of Kansas Radiation Oncology KU Cancer Center KU Medical Center and authors from around the world on a rapidly evolving area in radiation oncology! orit Kaidar-person Simon Lo The University of Kansas Health System

Congratulations to Kenny Guida, Dr. Lominska, Dr. Chen, Dr. Gan, Rajeev Badkul, Dima Soultan, Dr. Li, Dr. Saha, Dr. Kimler, Dr. Reddy, Dr. Gupta-Burt, Dr. Wang, Dr. Awan and Dr. Keleti for authoring @Hypofractionated and Stereotactic Radiation Therapy: A Practical Guide, 2nd